| ²é¿´: 2114 | »Ø¸´: 3 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
wzq70402¾èÖú¹ó±ö (СÓÐÃûÆø)
|
[ÇóÖú]
ÇëÎÊ´ó¼ÒÕâ¸öµ¥´ÊÈçºÎÒ룬ÊÇʲôÒâ˼retro-inverso modified peptides
|
||
|
ÇëÎÊ´ó¼ÒÕâ¸öµ¥´ÊÈçºÎÒ룬ÊÇʲôÒâ˼retro-inverso modified peptides Äæ·´ëÄ£¿Õâ¸ö´ÊÒâ˼Ӧ¸ÃëÄÀ໯ºÏÎï½á¹¹Öа±»ùËáL¸ÄÐÔ±äΪDÐÍ£¬´ó¼Ò¿´ÊDz»ÊÇ£¿ [ À´×Ô¿ÆÑмÒ×å Ò©Îﻯѧ¼Ò×å ] [ Last edited by wzq70402 on 2011-9-25 at 12:56 ] |
» ²ÂÄãϲ»¶
¡¾¿¼Ñе÷¼Á¡¿»¯Ñ§×¨Òµ 281·Ö£¬Ò»Ö¾Ô¸ËÄ´¨´óѧ£¬³ÏÐÄÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
317Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
0817 »¯Ñ§¹¤³Ì 299·ÖÇóµ÷¼Á ÓпÆÑоÀú ÓжþÇøÎÄÕÂ
ÒѾÓÐ10È˻ظ´
Ò»Ö¾Ô¸ Î÷±±´óѧ £¬070300»¯Ñ§Ñ§Ë¶£¬×Ü·Ö287£¬Ë«·ÇÒ»±¾£¬Çóµ÷¼Á¡£
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸¸£´ó288Óлú»¯Ñ§£¬Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
085600²ÄÁÏÓ뻯¹¤Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸Î÷°²½»Í¨´óѧ²ÄÁϹ¤³Ìרҵ 282·ÖÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
085600²ÄÁÏÓ뻯¹¤µ÷¼Á 324·Ö
ÒѾÓÐ10È˻ظ´
294Çóµ÷¼Á²ÄÁÏÓ뻯¹¤×¨Ë¶
ÒѾÓÐ11È˻ظ´
Ò»Ö¾Ô¸Äϲý´óѧ£¬327·Ö£¬²ÄÁÏÓ뻯¹¤085600
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÍòÄܵÄСľ³æ°¡£¬Çë¸æËßÎÒ£¬RGOµÄÀÂü¹âÆ×¾¿¾¹±í´ïÁËÔõÑùµÄÒâ˼°¡£¿
ÒѾÓÐ9È˻ظ´
»ÆÒâ»¶µÄ²èѧʵÑé¼¼ÊõÖвèÉ«ËØµÄ²âÁ¿£¬ÄÇÈý¸ö¹«Ê½µ½µ×ʲôÒâË¼ÄØ£¿
ÒѾÓÐ18È˻ظ´
Õâ·âÓʼþʲôÒâ˼¡£¡£¡£¡£
ÒѾÓÐ26È˻ظ´
¶ÔÂÁºÏ½ð×öXRDʱ£¬´ò³öÀ´µÄAl·å³ÆÖ®Îª¦Á-Al£¬Õâ¸ö¦Á-AlÊÇʲôÒâ˼
ÒѾÓÐ20È˻ظ´
Ϊʲôһ¸öµ¥´ÊÓÐÄÇô¶àÒâ˼£¬ÎªÊ²Ã´¼ÇÁ˵¥´ÊÒ²²»»á·Òë
ÒѾÓÐ8È˻ظ´
ÇóÖú£¡ÇëÎÊÕâ¸öµ¥´ÊʲôÒâ˼£¿¸ßÊÖÀ´
ÒѾÓÐ10È˻ظ´
×î¼ÑµÄ¼ÇÒäµ¥´ÊÈí¼þ£¬¸ú´ó¼Ò¹²ÏíÒ»ÏÂ
ÒѾÓÐ5È˻ظ´
¡¾×ÊÔ´¡¿Ó¢Óïµ¥´Ê²»ÊÇËÀ¼ÇÓ²±³µÄ
ÒѾÓÐ24È˻ظ´
benzenetriyl --Õâ¸öµ¥´ÊÊÇʲôÒâ˼£¿
ÒѾÓÐ5È˻ظ´

zhangyh1752
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 7079.7
- É¢½ð: 475
- ºì»¨: 7
- Ìû×Ó: 449
- ÔÚÏß: 245.7Сʱ
- ³æºÅ: 743653
- ×¢²á: 2009-04-08
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
¡ï
zznjut(½ð±Ò+1): »¶Ó 2011-10-23 20:17:00
zznjut(½ð±Ò+1): »¶Ó 2011-10-23 20:17:00
| partially modified retro-inverso(PMRI) peptides,ÎÒÒ²¿´µ½ÎÄÏ×ÕâÑùд Àí½âÆðÀ´ºÜ²»ºÃÀí½â |
4Â¥2011-10-23 15:57:18
yzkww
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 3788.8
- ºì»¨: 1
- Ìû×Ó: 114
- ÔÚÏß: 41.1Сʱ
- ³æºÅ: 1180896
- ×¢²á: 2010-12-30
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï
wgs8136(½ð±Ò+3): ¸ÐлӦÖú£¬¹ÄÀøÐ³淢Ìû½»Á÷ ~ 2011-09-27 12:07:14
wzq70402(½ð±Ò+3): ͬÒâ 2011-10-06 17:20:19
wgs8136(½ð±Ò+3): ¸ÐлӦÖú£¬¹ÄÀøÐ³淢Ìû½»Á÷ ~ 2011-09-27 12:07:14
wzq70402(½ð±Ò+3): ͬÒâ 2011-10-06 17:20:19
|
ÎÒ¾õµÃ¿ÉÄÜÊǹ¹ÐͺÍ˳Ðò¶¼Ïà·´²Å½Ðretro-invers¡£ retroÖ¸µÄÊÇÄæË³Ðò£¬inversoÖ¸µÄÊǹ¹Ðͷת¡£ |
2Â¥2011-09-27 11:48:00
grayong
¾èÖú¹ó±ö (ÖøÃûдÊÖ)
- Ó¦Öú: 74 (³õÖÐÉú)
- ½ð±Ò: 9738.6
- É¢½ð: 1036
- ºì»¨: 15
- Ìû×Ó: 1692
- ÔÚÏß: 244.9Сʱ
- ³æºÅ: 468006
- ×¢²á: 2007-11-27
- ÐÔ±ð: GG
- רҵ: ¹¦ÄÜÓëÖÇÄܸ߷Ö×Ó
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
wzq70402(½ð±Ò+2): лл 2011-10-06 17:20:30
zznjut(½ð±Ò+2): »¶Ó 2011-10-23 20:16:52
wzq70402(½ð±Ò+2): лл 2011-10-06 17:20:30
zznjut(½ð±Ò+2): »¶Ó 2011-10-23 20:16:52
|
A "retro-inverso peptide", as used herein, refers to a peptide with a reversal of the direction of the peptide bond at at least one position, i.e., a reversal of the amino- and carboxy-termini with respect to the side chain of the amino acid. Retro-inverso peptides may contain L-amino acids or D-amino acids, or a mixture of L-amino acids and D-amino acids. The term ¡°retro-inverso isomer¡± refers to an isomer of a linear peptide in which the direction of the sequence is reversed and the chirality of each amino acid residue is inverted. See, e.g., Jameson et al., Nature, 368, 744-746 (1994); Brady et al., Nature, 368, 692-693 (1994). Ï£ÍûÒÔÉÏÁ½¸ö½âÊÍÄÜÓÐËù°ïÖú¡£ |
3Â¥2011-09-27 17:30:39













»Ø¸´´ËÂ¥